Knowledge and technology transfer, or KTT, played a role in the creation of everything from Google to Gatorade. The Graphene Flagship explores this growing field, and how it connects academia with industry.
Audrey Franceschi Biagioni is investigating whether graphene flakes could help to alleviate psychological disorders related to the human fear response, such as post-traumatic stress disorder (PTSD).
Graphene Connect & Health Investment Forum brings together experts in graphene, investors and business leaders from the healthcare and medical communities, bridging valuable connections between academia and industry.
Biomedical tools manufactured with graphene and related materials will have to overcome a huge hurdle – our immune system. Now, G-IMMUNOMICS studied how to ‘disguise’ graphene to avoid rejection.